AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

QNCX · NASDAQ · Biotechnology

Quince Therapeutics (QNCX)

Develops inhaled sirolimus for pulmonary hypertension and bronchiolitis obliterans syndrome.

$31.61

Pre-market−0.94 (−2.89%)

At close$32.55(+1.37%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions30 holders · as of Jun 30, 2026	32.45%	330.1K shares
Insiders4 holders · as of Dec 29, 2025	0.75%	7.6K shares
Otherremainder	66.80%	679.4K shares

1.02M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (1.02M in the company's Sep 3, 2026 report, 278.4K elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Ikarian Capital, LLCInstitution	7.10%	72,251	13Fas of Jun 30, 2026
Millennium Management LLCInstitution	6.96%	70,779	13Fas of Jun 30, 2026
Balyasny Asset Management L.P.Institution	6.88%	69,967	13Fas of Jun 30, 2026
Squadron Master Fund LPInstitution	5.42%	55,173	13Gfiled Aug 4, 2026 ↗
Squadron Capital Management LLCInstitution	3.97%	40,375	13Fas of Jun 30, 2026
Shay Capital LLCInstitution	1.72%	17,468	13Fas of Jun 30, 2026
Boothbay Fund Management, LLCInstitution	1.37%	13,911	13Fas of Jun 30, 2026
Jane Street Group, LLCInstitution	1.24%	12,642	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	1.18%	12,044	13Fas of Jun 30, 2026
Cormorant Asset Management, LPInstitution	0.54%	5,498	13Fas of Jun 30, 2026
Dirk ThyeInsiderdirector, officer: CEO and CMO	0.49%	4,974	Form 4filed Dec 12, 2025 ↗
UBS Group AGInstitution	0.47%	4,730	13Fas of Jun 30, 2026
Morgan StanleyInstitution	0.40%	4,084	13Fas of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution	0.36%	3,614	13Fas of Jun 30, 2026
Brendan HannahInsiderofficer: CBO, COO & CCO	0.18%	1,809	Form 4filed Dec 8, 2025 ↗
BlackRock, Inc.Institution	0.17%	1,702	13Fas of Jun 30, 2026
Charles S. RyanInsiderofficer: President	0.06%	650	Form 4filed Jun 23, 2025 ↗
Tower Research Capital LLC (TRC)Institution	0.06%	567	13Fas of Jun 30, 2026
Luca BenattiInsiderdirector	0.02%	196	Form 4filed Dec 29, 2025 ↗
Gen-Wealth Partners IncInstitution	0.02%	165	13Fas of Jun 30, 2026
Operose Advisors LLCInstitution	0.02%	159	13Fas of Jun 30, 2026
Fortitude Family Office, LLCInstitution	0.00%	40	13Fas of Jun 30, 2026
Barclays PLCInstitution	0.00%	27	13Fas of Jun 30, 2026
Integrated Wealth Concepts LLCInstitution	0.00%	12	13Fas of Jun 30, 2026
Wells Fargo & Company/MNInstitution	0.00%	10	13Fas of Jun 30, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

30 holders · 330.1K shares

Holder	Shares	% outstanding	Filed
Ikarian Capital, LLC	72.3K	7.10%	Aug 14, 2026
Millennium Management LLC	70.8K	6.96%	Aug 14, 2026
Balyasny Asset Management L.P.	70.0K	6.88%	Aug 14, 2026
Squadron Capital Management LLC	40.4K	3.97%	Aug 14, 2026
Shay Capital LLC	17.5K	1.72%	Aug 14, 2026
Boothbay Fund Management, LLC	13.9K	1.37%	Aug 14, 2026
Jane Street Group, LLC	12.6K	1.24%	Aug 14, 2026
Vanguard Capital Management LLC	12.0K	1.18%	Aug 13, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Group One Trading LLC	10.70%		13G	Mar 5, 2026 ↗
David A. Lamond	10.10%		13D	Nov 13, 2024 ↗
Balyasny Asset Management L.P.	9.99%	97.7K	13G	Aug 14, 2026 ↗
Cormorant Asset Management, LP	9.99%	108.0K	13G	Aug 14, 2026 ↗
Ikarian Capital, LLC	9.00%	91.8K	13G	Aug 14, 2026 ↗
Nantahala Capital Management, LLC	7.52%		13G	May 15, 2026 ↗
Integrated Core Strategies (US) LLC	7.20%		13G	Jun 10, 2026 ↗
Squadron Master Fund LP	5.60%	55.2K	13G	Aug 4, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Dec 26, 2025	Luca Benattidirector	Sale	50,000	$3.47	39,179

CongressHouse and Senate disclosures

Not reported.